Literature DB >> 15210046

Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol.

Saipin Pongsatha1, Theera Tongsong.   

Abstract

OBJECTIVE: To assess the efficacy and maternal side-effects of oral misoprostol for second trimester termination of pregnancies with intrauterine fetal death.
METHODS: A prospective descriptive study was conducted on 63 pregnant women who had intrauterine fetal death with unfavorable cervix (Bishop scores </=4). All received 400 micro g of misoprostol orally every 4 h until favorable cervix was achieved. Main outcome measures included success rate of termination within 12, 24, 36 and 48 h, mean induction to delivery time and maternal side-effects.
RESULTS: The success rates of termination within 12, 24, 36, 48 h were 50.8%, 84.1%, 88.9% and 92.1%, respectively. Mean induction to delivery time in cases of delivery within 48 h was 13.2 +/- 8.4 h, range 2.25-22.9 h. The most common maternal side-effect was chill (33.3%). No serious maternal complication was detected.
CONCLUSION: 400 micro g oral misoprostol every 4 h is effective for pregnancy termination in cases of intrauterine fetal death and may be an alternative regimen because of its ease and convenience.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210046     DOI: 10.1111/j.1447-0756.2004.00184.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  3 in total

1.  A Study of Efficacy of Misoprostol in Missed Abortion.

Authors:  S Chawla
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy.

Authors:  Tripti Nagaria; Namrata Sirmor
Journal:  J Obstet Gynaecol India       Date:  2012-02-14

3.  Outcomes of Pregnancy Termination of Dead Fetus in Utero in Second Trimester by Misoprostol with Various Regimens.

Authors:  Saipin Pongsatha; Nuchanart Suntornlimsiri; Theera Tongsong
Journal:  Int J Environ Res Public Health       Date:  2022-10-03       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.